| 产品描述: | RP101988, the major active metabolite of Ozanimod, is a selective, potent S1PR1 (sphingosine-1-phosphate receptor 1) agonist, with EC50s of 0.19 nM and 32.8 nM for S1PR1 and S1PR5, respectivlely. |
| 靶点: |
S1PR1:0.19 nM (EC50); S1PR5:32.8 nM (EC50) |
| 体内研究: |
RP101988 is a substrate of P-gp and breast cancer resistance protein (BCRP) drug transporters. |
| 参考文献: |
1. Tran JQ, et al. Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study. Clin Pharmacol Drug Dev. 2018;7(3):263-276. 2. Gilardi D, et al. PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD [published online ahead of print, 2020 Jul 1]. Expert Rev Gastroenterol Hepatol. 2020;1-10. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.39 ml |
11.949 ml |
23.898 ml |
| 5 mM |
0.478 ml |
2.39 ml |
4.78 ml |
| 10 mM |
0.239 ml |
1.195 ml |
2.39 ml |
| 50 mM |
0.048 ml |
0.239 ml |
0.478 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |